(Q42167768)

English

Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

author name string

Judith Baumeister

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Ruediger Fischer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Peter Eckenberg

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kerstin Henninger

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Helga Ruebsamen-Waigmann

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Gerald Kleymann

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

35-48

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Once-daily valacyclovir to reduce the risk of transmission of genital herpes

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Herpes simplex virus latency and nucleoside analogues

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Alteration of Mortality and Pathogenesis of Three Experimental Herpesvirus hominis Infections of Mice with Adenine Arabinoside 5′-Monophosphate, Adenine Arabinoside, and Phosphonoacetic Acid

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Helicase primase: targeting the Achilles heel of herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Agents and strategies in development for improved management of herpes simplex virus infection and disease.

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Recurrent genital infection in the guinea pig: differences between herpes simplex types 1 and 2

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses r

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Patients' perspectives on the burden of recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Effect of Acyclovir on Genital Herpes in Guinea Pigs

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Perinatal herpesvirus infections. Herpes simplex, varicella, and cytomegalovirus

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent Disease

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Recurrent genital herpes simplex virus infection in guinea pigs

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Preclinical development of antiviral drugs

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Virologic characteristics of subclinical and symptomatic genital herpes infections

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800104

21 January 2018

Identifiers

10.1177/095632020701800104

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42167768&oldid=1935108908"